I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

CLSD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.20%

Insider Buying (Last 12 Months): $728,031.93

Insider Selling (Last 12 Months): $39,372.00

Clearside Biomedical Insider Trading History Chart

Clearside Biomedical Share Price & Price History

^$0.87

▼ -0.0577 (-6.20%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.

Clearside Biomedical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/1/2024	Ngai Hang Victor Chong	Insider	Buy	36,500	$1.00	$36,500.00	100,000
6/24/2024	Ngai Hang Victor Chong	Insider	Buy	23,500	$1.06	$24,910.00	63,500
5/15/2024	Benjamin R Yerxa	Director	Buy	7,813	$1.31	$10,235.03	17,957
4/17/2024	Anthony S Gibney	Director	Buy	6,710	$1.25	$8,387.50	6,710
3/20/2024	Ngai Hang Victor Chong	Insider	Buy	30,000	$1.60	$48,000.00	30,000
2/7/2024	Bradford T. Whitmore	Major Shareholder	Buy	444,444	$1.35	$599,999.40	4,495,034
1/19/2024	Charles A. Deignan	CFO	Sell	12,900	$1.28	$16,512.00	384,662
1/19/2024	George M. Lasezkay	CEO	Sell	18,000	$1.27	$22,860.00	466,577
11/1/2023	Bradford T. Whitmore	Major Shareholder	Buy	64,366	$0.74	$47,630.84	4,050,590
10/30/2023	Bradford T. Whitmore	Major Shareholder	Buy	600	$0.69	$414.00	3,915,412
10/3/2023	Nancy J Hutson	Director	Buy	10,000	$0.86	$8,600.00	93,000
9/25/2023	Clay Thorp	Director	Buy	10,000	$0.86	$8,600.00	40,522
1/20/2023	Thomas Ciulla	Insider	Sell	13,700	$1.47	$20,139.00	291,890
1/19/2023	Charles A. Deignan	CFO	Sell	14,030	$1.50	$21,045.00	363,472
1/19/2023	George M. Lasezkay	CEO	Sell	20,030	$1.46	$29,243.80	484,577
1/10/2023	Thomas Ciulla	Insider	Sell	2,170	$1.62	$3,515.40	305,590
12/21/2022	Clay Thorp	Director	Buy	14,000	$1.02	$14,280.00	30,522
11/17/2022	Nancy J Hutson	Director	Buy	30,000	$1.33	$39,900.00	83,000
1/19/2022	Charles A. Deignan	CFO	Sell	8,833	$2.09	$18,460.97
1/19/2022	George M. Lasezkay	CEO	Sell	10,800	$2.12	$22,896.00
1/19/2022	Thomas Ciulla	Insider	Sell	9,050	$2.13	$19,276.50
1/11/2022	George M. Lasezkay	CEO	Sell	5,100	$2.46	$12,546.00

AI breakthrough about to upend industry

From Porter & Company | Ad

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

I urge you to watch it now.

SEC Filings (Institutional Ownership Changes) for Clearside Biomedical (NASDAQ:CLSD)

18.75% of Clearside Biomedical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Clearside Biomedical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	731,386	$0.93M	0.0%	+8.8%	0.964%
11/14/2024	Johnson & Johnson	82,481	$0.11M	0.0%	N/A	0.110%
10/30/2024	Rosalind Advisors Inc.	127,220	$0.16M	0.1%	-95.1%	0.170%
10/23/2024	Assenagon Asset Management S.A.	257,103	$0.33M	0.0%	-9.2%	0.344%
8/15/2024	Armistice Capital LLC	2,136,000	$2.78M	0.0%	-46.0%	2.858%
8/12/2024	XTX Topco Ltd	54,313	$71K	0.0%	+172.2%	0.073%
8/9/2024	Renaissance Technologies LLC	582,689	$0.76M	0.0%	+6.6%	0.780%
7/30/2024	International Assets Investment Management LLC	20,000	$26K	0.0%	-44.4%	0.027%
7/18/2024	Assenagon Asset Management S.A.	283,193	$0.37M	0.0%	N/A	0.379%
5/10/2024	Vanguard Group Inc.	2,490,796	$3.81M	0.0%	+14.5%	3.333%
5/7/2024	SG Americas Securities LLC	32,270	$49K	0.0%	N/A	0.043%
4/25/2024	Rosalind Advisors Inc.	2,592,593	$3.97M	3.7%	N/A	3.470%
4/11/2024	International Assets Investment Management LLC	36,000	$57K	0.0%	N/A	0.048%
11/29/2023	Carmignac Gestion	2,132,744	$1.86M	0.0%	-11.1%	3.417%
8/8/2023	Brown Wealth Management LLC	110,000	$0.12M	0.1%	N/A	0.178%
8/7/2023	Acadian Asset Management LLC	34,165	$37K	0.0%	-75.1%	0.055%
7/27/2023	Virtu Financial LLC	33,844	$38K	0.0%	N/A	0.055%
7/27/2023	B. Riley Wealth Advisors Inc.	31,000	$35K	0.0%	N/A	0.050%
7/25/2023	Assenagon Asset Management S.A.	71,776	$80K	0.0%	-52.7%	0.116%
7/18/2023	Stratos Wealth Partners LTD.	39,442	$44K	0.0%	+56.6%	0.064%
5/25/2023	Water Island Capital LLC	65,000	$68K	0.0%	+38.3%	0.105%
4/28/2023	Janney Montgomery Scott LLC	100,000	$0.10M	0.0%	N/A	0.163%
4/27/2023	Stratos Wealth Partners LTD.	25,180	$26K	0.0%	N/A	0.041%
4/18/2023	Assenagon Asset Management S.A.	151,638	$0.16M	0.0%	-9.5%	0.247%
2/14/2023	Water Island Capital LLC	47,000	$53K	0.0%	N/A	0.078%
2/13/2023	Northeast Financial Consultants Inc	83,000	$93K	0.0%	+56.6%	0.138%
2/10/2023	Ameritas Advisory Services LLC	41,620	$47K	0.0%	+100.0%	0.069%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	57,034	$64K	0.0%	-15.1%	0.095%
2/10/2023	Banque Cantonale Vaudoise	40,000	$45K	0.0%	N/A	0.066%
2/9/2023	Hamilton Lane Advisors LLC	65,359	$73K	0.0%	N/A	0.109%
2/9/2023	Johnson & Johnson	169,629	$0.19M	0.1%	N/A	0.282%
2/2/2023	Bailard Inc.	47,800	$54K	0.0%	N/A	0.079%
1/12/2023	Assenagon Asset Management S.A.	167,582	$0.19M	0.0%	-59.2%	0.278%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	67,170	$76K	0.0%	+34.3%	0.112%
11/4/2022	Lincoln National Corp	92,300	$0.10M	0.0%	N/A	0.153%
11/3/2022	ACT Capital Management LLC	2,197,480	$2.48M	3.4%	-4.0%	3.651%
10/27/2022	Assenagon Asset Management S.A.	410,691	$0.46M	0.0%	-45.7%	0.682%
10/18/2022	Newman Dignan & Sheerar Inc.	27,023	$31K	0.0%	N/A	0.045%
8/12/2022	Carmignac Gestion	2,390,344	$3.51M	0.1%	-3.8%	3.974%
8/10/2022	Synovus Financial Corp	64,851	$95K	0.0%	-13.4%	0.108%
8/10/2022	Mackenzie Financial Corp	33,448	$49K	0.0%	+184.5%	0.056%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	50,029	$74K	0.0%	-36.9%	0.083%
7/27/2022	Assenagon Asset Management S.A.	756,200	$1.11M	0.0%	-17.2%	1.257%
5/13/2022	Carmignac Gestion	2,485,652	$5.69M	0.1%	-20.2%	4.132%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	79,252	$0.18M	0.0%	N/A	0.132%
5/11/2022	ACT Capital Management LLC	2,458,600	$5.63M	6.0%	-1.0%	4.087%
5/11/2022	GSA Capital Partners LLP	78,274	$0.18M	0.0%	N/A	0.130%
4/25/2022	Bailard Inc.	25,600	$59K	0.0%	N/A	0.043%
4/25/2022	Assenagon Asset Management S.A.	913,789	$2.09M	0.0%	-44.1%	1.519%
2/14/2022	PDT Partners LLC	10,616	$29K	0.0%	N/A	0.018%
2/11/2022	Northeast Financial Consultants Inc	53,000	$0.15M	0.0%	+307.7%	0.089%
2/10/2022	Exencial Wealth Advisors LLC	14,064	$39K	0.0%	N/A	0.024%
2/10/2022	OLD Mission Capital LLC	16,362	$45K	0.0%	N/A	0.027%
2/9/2022	Principal Financial Group Inc.	65,344	$0.18M	0.0%	N/A	0.110%
2/7/2022	Ameritas Advisory Services LLC	20,810	$57K	0.0%	N/A	0.035%
2/3/2022	Cambridge Investment Research Advisors Inc.	31,900	$88K	0.0%	-25.6%	0.053%
2/3/2022	ACT Capital Management LLC	2,483,500	$6.83M	4.9%	+0.6%	4.162%
2/1/2022	Assenagon Asset Management S.A.	1,634,412	$4.50M	0.0%	+8,559.6%	2.739%
1/13/2022	Wedbush Securities Inc.	36,239	$100K	0.0%	N/A	0.061%
11/16/2021	ACT Capital L.L.C.	2,467,500	$14.81M	7.7%	+0.2%	4.135%
11/16/2021	Squarepoint Ops LLC	15,466	$93K	0.0%	-62.9%	0.026%
11/16/2021	Two Sigma Advisers LP	1,011,400	$6.07M	0.0%	+2.2%	1.700%
11/16/2021	Two Sigma Investments LP	827,499	$4.97M	0.0%	-23.8%	1.391%
11/15/2021	Cubist Systematic Strategies LLC	79,967	$0.48M	0.0%	+200.0%	0.134%
11/15/2021	Marshall Wace LLP	53,474	$0.32M	0.0%	-76.8%	0.090%
11/15/2021	Caxton Associates LP	66,569	$0.40M	0.0%	+169.8%	0.112%
11/15/2021	Capstone Investment Advisors LLC	11,856	$71K	0.0%	N/A	0.020%
11/15/2021	Invesco Ltd.	277,161	$1.66M	0.0%	N/A	0.466%
11/15/2021	Dynamic Technology Lab Private Ltd	39,745	$0.24M	0.0%	N/A	0.067%
11/15/2021	Franklin Resources Inc.	111,900	$0.67M	0.0%	N/A	0.188%
11/12/2021	Trexquant Investment LP	43,768	$0.26M	0.0%	N/A	0.074%
11/12/2021	Renaissance Technologies LLC	101,489	$0.61M	0.0%	+43.8%	0.171%
11/12/2021	Ameritas Investment Company LLC	60,810	$0.37M	0.0%	+19.7%	0.102%
11/12/2021	Jump Financial LLC	38,169	$0.23M	0.0%	N/A	0.064%
11/12/2021	Geode Capital Management LLC	486,642	$2.92M	0.0%	+14.9%	0.818%
11/10/2021	Goldman Sachs Group Inc.	46,816	$0.28M	0.0%	+179.2%	0.079%
11/9/2021	Barclays PLC	17,048	$0.10M	0.0%	N/A	0.029%
11/9/2021	BlackRock Inc.	804,352	$4.83M	0.0%	+4.3%	1.352%
11/5/2021	Advisor Group Holdings Inc.	9,350	$56K	0.0%	+26.4%	0.016%
11/2/2021	Cambridge Investment Research Advisors Inc.	42,850	$0.26M	0.0%	+41.9%	0.072%
10/19/2021	Assenagon Asset Management S.A.	18,874	$0.11M	0.0%	N/A	0.032%
10/7/2021	Newman Dignan & Sheerar Inc.	21,523	$0.13M	0.0%	N/A	0.036%
8/25/2021	Marshall Wace LLP	230,441	$1.12M	0.0%	-31.0%	0.387%
8/17/2021	Walleye Capital LLC	18,000	$88K	0.0%	N/A	0.030%
8/17/2021	Millennium Management LLC	175,035	$0.85M	0.0%	-6.1%	0.294%
8/17/2021	Price T Rowe Associates Inc. MD	37,200	$0.18M	0.0%	-25.0%	0.063%
8/17/2021	Acuta Capital Partners LLC	1,316,268	$6.41M	2.6%	-18.4%	2.213%
8/17/2021	Bridgeway Capital Management LLC	316,600	$1.54M	0.0%	+14.5%	0.532%
8/16/2021	Squarepoint Ops LLC	41,663	$0.20M	0.0%	-58.6%	0.070%
8/16/2021	Ameritas Investment Company LLC	50,810	$0.25M	0.0%	N/A	0.085%
8/16/2021	Cubist Systematic Strategies LLC	26,656	$0.13M	0.0%	+29.4%	0.045%
8/16/2021	Caxton Associates LP	24,677	$0.12M	0.0%	N/A	0.041%
8/16/2021	Charles Schwab Investment Management Inc.	28,221	$0.14M	0.0%	+136.6%	0.047%
8/16/2021	State Street Corp	165,588	$0.81M	0.0%	+316.7%	0.278%
8/16/2021	Marshall Wace LLP	230,441	$1.12M	0.0%	-31.0%	0.387%
8/13/2021	Renaissance Technologies LLC	70,589	$0.34M	0.0%	-87.5%	0.119%
8/13/2021	Stifel Financial Corp	14,494	$71K	0.0%	-22.7%	0.025%
8/13/2021	Carmignac Gestion	3,419,877	$16.66M	0.2%	-3.4%	5.939%
8/13/2021	Geode Capital Management LLC	423,541	$2.06M	0.0%	+16.1%	0.736%
8/13/2021	Vanguard Group Inc.	2,106,090	$10.26M	0.0%	+21.9%	3.658%

Data available starting January 2016

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Today's Range

Now: $0.87

$0.80

$0.93

50 Day Range

MA: $1.06

$0.87

$1.32

52 Week Range

Now: $0.87

$0.80

$2.12

Volume

946,480 shs

Average Volume

389,719 shs

Market Capitalization

$66.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.29

Who are the company insiders with the largest holdings of Clearside Biomedical?: Clearside Biomedical's top insider investors include:
Bradford T Whitmore (Major Shareholder)
George M Lasezkay (CEO)
Charles A Deignan (CFO)
Thomas Ciulla (Insider)
Ngai Hang Victor Chong (Insider)
Nancy J Hutson (Director)
Clay Thorp (Director)
Benjamin R Yerxa (Director)
Anthony S Gibney (Director)
Learn More about top insider investors at Clearside Biomedical.
Who are the major institutional investors of Clearside Biomedical?: Clearside Biomedical's top institutional shareholders include:
Geode Capital Management LLC — 0.96%
Assenagon Asset Management S.A. — 0.34%
Rosalind Advisors Inc. — 0.17%
Johnson & Johnson — 0.11%
Learn More about top institutional investors of Clearside Biomedical stock.
Which major investors are selling Clearside Biomedical stock?: During the previous quarter, CLSD stock was sold by these institutional investors:
Rosalind Advisors Inc.
Assenagon Asset Management S.A.
During the previous year, company insiders that have sold Clearside Biomedical company stock include:
Bradford T Whitmore (Major Shareholder)
George M Lasezkay (CEO)
Learn More investors selling Clearside Biomedical stock.
Which major investors are buying Clearside Biomedical stock?: In the last quarter, CLSD stock was acquired by institutional investors including:
Johnson & Johnson
Geode Capital Management LLC
In the previous year, these company insiders have bought Clearside Biomedical stock:
Bradford T Whitmore (Major Shareholder)
George M Lasezkay (CEO)
Charles A Deignan (CFO)
Thomas Ciulla (Insider)
Ngai Hang Victor Chong (Insider)
Nancy J Hutson (Director)
Learn More investors buying Clearside Biomedical stock.